Culture medium and method for inhibiting cell aging through mesenchymal stem cell amplification
By adding cAMP pathway activator forskolin and DYRK1 inhibitor INDY to the culture medium of mesenchymal stem cells, a culture medium that inhibits cell aging was formed, which solved the problem of cell aging in two-dimensional plane culture and achieved long-term high efficiency of cells The maintenance of amplification and multidirectional differentiation capabilities reduces costs and is easy to scale.
Patent Information
- Application Number
- CN202411385268.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-12-06
AI Technical Summary
In two-dimensional planar culture system, mesenchymal stem cells are prone to aging, resulting in their function decline and slowing down in long-term passage, affecting the effect and yield of cell therapy. There are high existing three-dimensional culture and genetic modification methods The problem of cost and difficulty in scale.
Using culture medium containing cAMP pathway activator Forskolin and bispecific psychophosphorylation regulator INDY, the cell basal medium was added by adding 10% fetal bovine serum, 10 μM forskolin and 20 μM INDY, regulate pH to 7.0-7.5, form a culture medium that inhibits cell aging, and performs cell expansion in a two-dimensional planar culture instrument.
It significantly delayed the aging of mesenchymal stem cells, maintained the multidirectional differentiation potential and proliferation ability of cells, and was able to maintain the expression of marker proteins and the three-way differentiation function after nearly 15 generations of culture. The proliferation rate and cell aging index were better than traditional culture media. P10 generation cells under conditions.
Smart Images

Figure CN119082011A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a culture medium and a method for expanding mesenchymal stem cells and inhibiting cell aging, belonging to the technical field of stem cells. Background Art
[0002] Mesenchymal stem cells (MSCs) play multiple roles in cell and tissue repair therapy, and are considered to be an important drug for clinical cell therapy due to their good accessibility and versatility. However, the number of MSCs in various tissues of adult individuals is relatively small, which limits their direct application in clinical treatment. In order to obtain sufficient cell quantity to meet the needs of clinical administration, MSCs derived from adult tissues must be expanded in vitro, a process that often requires long-term passaging.
[0003] The traditional MSC expansion method mainly uses the planar two-dimensional system expansion method. This method has some limitations. Cells that are passaged in a two-dimensional planar system for a long time may experience problems such as functional decline, aging, and slowed proliferation rate. In particular, cell aging will significantly affect the final effect of cell therapy. In order to ensure the efficacy, it is usually recommended to use MSCs from human and animal adult tissues that have been expanded in vitro for 4 to 6 generations. Therefore, how to overcome the problem of MSC aging in a two-dimensional planar culture system and how to improve the expansion ability of these cells during long-term passage has become a technical problem that needs to be solved in the field of stem cell therapy. Whether this technical problem is solved is directly related to the efficacy and yield of the cells, and has a significant impact on improving the success rate of clinical treatment.
[0004] In order to solve the above technical problems, technicians in this field are exploring a variety of new methods and technologies. The three-dimensional culture system can provide cells with an environment that is closer to the physiological state, which helps to maintain the multidirectional differentiation potential of cells and prolong the life cycle of cells. In addition, automated and computer-controlled bioreactor technology can provide more precise and controllable culture conditions and optimize the expansion efficiency of cells; the application of genetic modification technology, such as CRISPR-Cas9 gene knockout technology, viral overexpression system, etc., also provides new possibilities for improving the characteristics and functions of MSCs.
[0005] However, methods such as 3D culture, automated control and genetic modification have disadvantages such as high cost and difficulty in scalability. If the aging and proliferation ability of MSCs can be improved in a two-dimensional planar expansion system, the effect of reducing costs and facilitating scalability can be achieved, it will help solve the problems faced by the industrialization of MSC cells. Summary of the invention
[0006] In view of the above technical problems in the prior art, the present invention provides a culture medium and method for expanding mesenchymal stem cells and inhibiting cell aging.
[0007] The technical solution of the present invention to solve the above technical problems is as follows:
[0008] One of the purposes of the present invention is to provide a culture medium for mesenchymal stem cell proliferation and inhibition of cell aging, comprising a cAMP (cyclic adenosine monophosphate) pathway activator and a dual-specific tyrosine phosphorylation-regulated kinase inhibitor.
[0009] On the basis of the above technical solution, the present invention can also make the following improvements:
[0010] Furthermore, the cAMP pathway activator is forskolin.
[0011] Furthermore, the dual-specific tyrosine phosphorylation-regulated kinase inhibitor is INDY, wherein INDY is 1-(3-ethyl-5-hydroxy-1,3-benzothiazole-2-methylene)propanone, and its CAS number is 1169755-45-6.
[0012] Furthermore, the culture medium for expanding mesenchymal stem cells and inhibiting cell aging includes a cell basal culture medium, 10% fetal bovine serum by volume, 10 μM forskolin, and 20 μM INDY.
[0013] Furthermore, the cell basal culture medium is DMEM low-glucose culture medium.
[0014] Furthermore, the preparation process of the culture medium for mesenchymal stem cell expansion and inhibition of cell aging includes the following steps:
[0015] (1) Prepare cell basal culture medium, fetal bovine serum, 10 mM forskolin, 20 mM INDY, and pH regulator;
[0016] (2) adding fetal bovine serum, forskolin, and INDY to the cell basal culture medium according to the composition and ratio of each component, and mixing evenly;
[0017] (3) Adjusting pH: Detecting the pH value of the primary culture medium obtained in step (2), adjusting the pH value to 7.0-7.5, filtering, and obtaining the culture medium for mesenchymal stem cell proliferation and inhibition of cell aging. After rewarming at room temperature, the culture medium can be used for MSC culture.
[0018] Furthermore, the pH regulator is NaOH solution and NaHCO3 solution, wherein the concentration of NaOH solution is 1 mol / L, and the mass volume fraction of NaHCO3 solution is 1%.
[0019] Further, in step (1),
[0020] The preparation of forskolin includes: adding forskolin into dimethyl sulfoxide and dissolving it completely to obtain a forskolin concentration of 10 mM;
[0021] The preparation of INDY includes: adding INDY into dimethyl sulfoxide and dissolving it completely to obtain 20 mM concentration of INDY.
[0022] The second object of the present invention is to provide a method for expanding mesenchymal stem cells and inhibiting cell aging, using the above-mentioned culture medium for expanding mesenchymal stem cells and inhibiting cell aging, and selecting a two-dimensional planar culture as the culture method.
[0023] Furthermore, the above method specifically comprises the following steps:
[0024] (1) After the mesenchymal stem cells are revived or digested by passage, the residual cryopreservation solution is removed by centrifugation to collect single cells, and the cells are resuspended in the medium for expanding the mesenchymal stem cells and inhibiting cell aging, and the cells are concentrated to 2.0×10 6 The cells were seeded at a density of 10 cells / cm2 in a two-dimensional culture vessel and cultured statically in a cell culture incubator at 37°C and 5% CO2;
[0025] (2) Subculturing after 4-5 days of culture: changing the medium every day, and observing the cell morphology and confluence. When the confluence reaches more than 80%, use trypsin or accutase to digest the cells. After terminating the digestion with a culture medium containing fetal bovine serum, centrifuge and count, and continue to repeat the inoculation method in (1) to perform two-dimensional static culture;
[0026] (3) Subsequent subculturing: Culture the cells as described in (2), subculturing them every 4-5 days. Digest the cells into single cells using trypsin or accutase, and subculture them as described above.
[0027] Furthermore, the two-dimensional planar culture vessel is a culture bottle, a culture dish or a culture well plate.
[0028] The beneficial effects of the present invention are as follows: the present invention proposes a method for promoting the in vitro expansion of mesenchymal stem cells and delaying cell aging by using a cAMP pathway activator Forskolin and a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK1 protein) inhibitor INDY. After MSCs are cultured for nearly 15 generations using the culture medium of the present invention, surface marker proteins and tri-directional differentiation functions remain normal. At the same time, compared with P10 generation MSCs cultured in conventional culture medium, they have significant improvements in indicators such as proliferation rate and cell aging. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 It is the cumulative cell population doubling number of P2-P10 generations of mesenchymal stem cells in different culture media;
[0030] Figure 2 Flow cytometry detection of MSC marker proteins after 15 generations of expansion in medium containing Forskolin and INDY;
[0031] Figure 3 To detect the tri-differentiation ability of MSCs after 15 generations of expansion in medium containing Forskolin and INDY;
[0032] Figure 4 is an aging marker (β-galactosidase activity) of MSCs of generation P15 in group 1 and generation P10 in group 2 in a specific embodiment;
[0033] Figure 5 is the positive ratio of β-galactose staining of MSCs of generation P15 in group 1 and generation P10 in group 2 in a specific embodiment;
[0034] Figure 6 The cell size of group 1 P15 MSC and group 2 P10 MSC in a specific embodiment. DETAILED DESCRIPTION
[0035] The principles and features of the present invention are described below in conjunction with the accompanying drawings. The examples given are only used to explain the present invention and are not used to limit the scope of the present invention.
[0036] 1. cAMP pathway activator Forskolin and DYRK1 protein inhibitor INDY synergistically promote the expansion of canine mesenchymal stem cells in vitro
[0037] (1) Culture medium preparation
[0038] ①Material preparation:
[0039] Culture medium A: DMEM low-glucose culture medium + 10% FBS + 5ng / mL bFGF; the preparation process is: add 50mL FBS (fetal bovine serum) to 450mL DMEM low-glucose culture medium, and add 0.05mL bFGF with a concentration of 50μg / mL;
[0040] Culture medium B: DMEM low glucose culture medium + 10% FBS + 10 μM Forskolin; the preparation process is: add 50 mL FBS (fetal bovine serum) to 450 mL DMEM low glucose culture medium, and add 0.5 mL Forskolin to a final concentration of 10 μM;
[0041] Culture medium C: DMEM low-glucose culture medium + 10% FBS + 20 μM INDY; the preparation process is: add 50 mL FBS (fetal bovine serum) to 450 mL DMEM low-glucose culture medium, and add 0.5 mL INDY to a final concentration of 20 μM;
[0042] Medium D (i.e., the medium for mesenchymal stem cell expansion and inhibition of cell aging of the present invention): DMEM low-glucose medium + 10% FBS + 10 μM Forskolin + 20 μM INDY; the preparation process is: 50 mL FBS (fetal bovine serum) is added to 450 mL DMEM low-glucose medium, 0.5 mL Forskolin is added to a final concentration of 10 μM and 0.5 mL INDY is added to a final concentration of 20 μM.
[0043] in:
[0044] The forskolin used in the above culture medium has a CAS number of 66575-29-9, a brand of MCE, and a product number of HY-15371;
[0045] The above culture medium uses INDY (DYRK1 inhibitor), CAS number: 1169755-45-6, brand MCE, product number HY-108476;
[0046] The configuration of the forskolin includes: 10 mg forskolin is added to 2.4361 mL DMSO and completely dissolved to obtain a forskolin concentration of 10 mM;
[0047] The configuration of the above INDY includes: 20 mg INDY is added into 4.2499 mL DMSO and completely dissolved to obtain 20 mM concentration of INDY;
[0048] In the DMEM low-glucose culture medium, the full name of the DMEM culture medium is Dulbecco's Modified Eagle's Medium culture medium. The culture medium used in this embodiment is Thermo Fisher, with a product number of 11885084.
[0049] ② Add other materials except DMEM low-glucose medium to DMEM low-glucose medium respectively, mix evenly, and obtain the primary medium;
[0050] ③ Adjusting pH: Detecting the pH value of the primary culture medium obtained in step ②, adding 250 μL-300 μL of 1% NaHCO3 solution to adjust the pH value to 7.2, filtering with a 0.22 μm filter to obtain the above-mentioned culture medium A, B, C, and D, respectively, rewarming at room temperature, and then using them for MSC 2D culture;
[0051] (2) Thawing cells: Take out the frozen canine mesenchymal stem cells from the liquid nitrogen tank, quickly transfer the cryopreserved tube to a water bath preheated at 37±2°C, shake the frozen cells continuously to thaw them quickly, and transfer the cell cryopreserved tube to a biosafety cabinet; in the biosafety cabinet, transfer 9.0 mL of DMEM low-glucose medium containing 10% FBS to a 15 mL centrifuge tube, take out the thawed cell suspension with a pipette and add it to the centrifuge tube, cover the centrifuge tube, and remove it from the biosafety cabinet for centrifugation;
[0052] (3) Cell centrifugation: fully mix the cell suspension in the centrifuge tube, tighten the centrifuge tube cap, transfer the centrifuge tube to a centrifuge, centrifuge at 200g-400g for 5 min, discard the supernatant, and retain the cell pellet;
[0053] (4) Resuspension and counting: Add 2 mL of the culture medium of each group prepared in (1) to each centrifuge tube to resuspend the cell pellet; use a 10 mL pipette to gently pipette the cell suspension to mix it thoroughly, and perform cell counting and viability detection;
[0054] (5) Cell seeding: 2.0x10 6 The cell suspension was inoculated into a T75 culture flask, and each group of culture medium prepared in (1) was added to a total volume of 15 mL. The culture flask was placed in a CO2 incubator at a temperature of 37.0°C and a CO2 concentration of 5.0%.
[0055] (6) Cell 2D culture medium replacement: The cells were cultured daily with 15 mL of the culture medium prepared in step (1) added. The cells were digested after proliferating to a confluence of about 85%.
[0056] (7) Cell digestion and passaging: The cells were washed once with DMEM / F12 medium, and Accutase was added to digest at 37°C for 4-5 minutes. The culture medium prepared in (1) was added to terminate the digestion. After the cells were centrifuged at 200g for 4 minutes, the cells were resuspended with the culture medium in (1). The cells were counted and the cell number was recorded for counting the proliferation times and summarizing the growth curve.
[0057] (8) The digested single cells were passaged according to the inoculation density in (5), and each group used a different culture medium. After cell inoculation, the culture flask was placed in a CO2 incubator at a temperature of 37.0°C and a CO2 concentration of 5.0%;
[0058] (9) After culturing to the 10th generation, the cell proliferation curve was drawn.
[0059] Results Figure 1After being cultured in different culture systems, the cells had the best proliferation effect in medium D with the addition of cAMP pathway activator Forskolin and DYRK1 protein (dual-specific tyrosine phosphorylation-regulated kinase) inhibitor INDY. The proliferation rate of the non-addition group (medium A) or the single addition group (medium B) decreased significantly in the P5-P10 generations.
[0060] 2. Flow cytometry and tri-directional differentiation ability testing of canine MSCs after 2D culture
[0061] 1. Canine MSC culture in 2D system:
[0062] The operation is the same as above, and the culture medium containing both Forskolin and INDY is used for culture.
[0063] 2. MSC index flow cytometry detection:
[0064] The culture medium containing both Forskolin and INDY was used for 2D culture in vitro expansion of P15 MSCs for flow cytometry detection of MSC indicators.
[0065] The flow detection process is as follows:
[0066] (1) Collect the culture medium to expand the P15 generation MSC in vitro, digest it into single cells, and then group it according to the cell quantity for each detection index. The CD34, CD29, CD90, and CD44 antibody detection groups require 1x10 cells per group. 6 indivual;
[0067] (2) Collect cells by centrifugation at 500 g for 5 min and discard the supernatant; resuspend in 400 μL PBS and centrifuge at 500 g for 5 min. Repeat twice and discard the supernatant.
[0068] (3) The resuspended cells were divided into two parts, each with 200 μL cell suspension. One part was for the isotype group: according to the instructions for use of each antibody, the corresponding volume of isotype was added and resuspended; the other part was for the experimental group: the corresponding volume of anti-CD90 / CD44 / CD29 / CD34 antibodies were added respectively, and incubated at 4°C in the dark for 30 minutes; after incubation, centrifuge at 4°C, 500g, 5min, collect the cells and discard the supernatant; add 500 μL PBS to resuspend, centrifuge at 4°C, 500g, 5min, collect the cells and discard the supernatant, repeat 3 times, add 200 μL PBS to resuspend, and use it for flow cytometry detection of the expression of each marker. Results refer to Figure 2 shown.
[0069] Figure 2The results showed that in the case of planar subculture, MSCs expanded in vitro by Forskolin and INDY 2D at P15 still maintained good expression of MSC marker proteins (positive markers CD29 / CD44 / CD90 were all greater than 90%, and negative marker CD34 was less than 2%).
[0070] The sources of the antibodies and related reagents used are shown in Table 1 below.
[0071] Table 1 Sources of reagents
[0072]
[0073] 3. Three-way differentiation ability detection:
[0074] The MSCs at the P15 generation were expanded in vitro using a medium containing both Forskolin and INDY for 2D culture and then subjected to in vitro three-way functional testing (i.e., osteogenic, adipogenic, and chondrogenic).
[0075] (1) Osteogenic induction (using Cyagen, CUXMD-90021, OriCell adipose-derived mesenchymal stem cell osteogenic differentiation kit):
[0076] ① Add 1 mL of 0.1% gelatin to the six-well plate and shake it well to evenly cover the bottom of each well;
[0077] ② Place the six-well plate covered with 0.1% gelatin in a clean bench or CO2 incubator for at least 30 minutes;
[0078] ③After 30 minutes, remove the gelatin and use it to inoculate cells, or wait for the six-well plate to dry before inoculation;
[0079] ④ The adipose-derived mesenchymal stem cells to be induced were divided into 2x10 4 The cells were seeded in six-well plates at a density of 1.5 cells / cm2, and 2 mL of normal complete medium (low-glucose DMEM + 10% FBS + 5 ng / mL bFGF) was added to each well;
[0080] ⑤ The cells were cultured in a CO2 incubator at 37°C, 5% CO2, and saturated humidity;
[0081] ⑥ When the cell confluence reaches 70%, carefully remove the normal complete medium in the well and add 2 mL of Oricell adipose-derived mesenchymal stem cell osteogenic differentiation medium to the six-well plate;
[0082] ⑦ Replace with fresh OriCell adipose-derived mesenchymal stem cell osteogenic differentiation medium every 3 days;
[0083] ⑧After 2-4 weeks of induction, the cells were stained with Alizarin Red depending on their morphological changes and growth.
[0084] (2) Adipogenic induction (using Cyagen, CUXMD-90031, OriCell adipose-derived mesenchymal stem cell adipogenic differentiation kit):
[0085] ① Add 1 mL of 0.1% gelatin to the six-well plate and shake it well to evenly cover the bottom of each well;
[0086] ② Place the six-well plate covered with 0.1% gelatin in a clean bench or CO2 incubator for at least 30 minutes;
[0087] ③After 30 minutes, remove the gelatin and use it to inoculate cells, or wait for the six-well plate to dry before inoculation;
[0088] ④ The adipose-derived mesenchymal stem cells to be induced were divided into 2x10 4 The cells were seeded in six-well plates at a density of 1.5 cells / cm2, and 2 mL of normal complete medium (low-glucose DMEM + 10% FBS + 5 ng / mL bFGF) was added to each well;
[0089] ⑤ The cells were cultured in a CO2 incubator at 37°C, 5% CO2, and saturated humidity;
[0090] ⑥ When the cell confluence reaches 100%, carefully remove the complete medium in the well and add 2 mL of medium A of the adipogenic differentiation kit to the six-well plate;
[0091] ⑦ After 3 days of induction, remove the A solution in the six-well plate and add 2 mL of the medium B solution of the adipogenic differentiation kit;
[0092] ⑧After 1 day, remove solution B and replace it with solution A for induction;
[0093] ⑨ Solution A and solution B are used alternately, and the cell status needs to be observed every day. If cell shrinkage or death occurs during the induction process of solution A, it needs to be replaced with solution B in time until the cell status recovers;
[0094] ⑩ Repeat the induction and maintenance process until obvious lipid droplets appear and then staining can be performed.
[0095] (3) Chondrogenic induction (using Cyagen, CUXMD-90041, OriCell adipose-derived mesenchymal stem cell chondrogenic differentiation kit):
[0096] ①4×10 5 Transfer the cells to be induced into a 15 mL centrifuge tube and centrifuge at 20°C, 250 g for 4 min;
[0097] ② Aspirate the supernatant, add 0.5 mL of the premixed solution of the chondrogenic differentiation kit, resuspend the precipitate obtained by centrifugation in the previous step, and centrifuge at 20°C, 150g for 5 minutes;
[0098] ③Repeat step ② and wash the cells again;
[0099] ④ Addition of Supplement II (hereinafter referred to as Supplement II) of the OriCell Adipose-derived Mesenchymal Stem Cell Chondrogenic Differentiation Kit: according to the ratio (10 μL of Supplement II is added to 1 mL of Chondrogenic Differentiation Premix), pipette the required dose of Supplement II into the corresponding volume of premix to prepare a complete chondrogenic differentiation medium, and mix by gently pipetting;
[0100] ⑤ Resuspend the cell pellet obtained in step ③ with 0.5 mL of complete chondrogenic differentiation medium and centrifuge at 20°C, 150 g for 5 min;
[0101] ⑥ Loosen the cap of the centrifuge tube to facilitate gas exchange, and place it upright in a CO2 incubator at 37°C, 5% CO2, and saturated humidity;
[0102] ⑦ When the cells begin to aggregate (usually after 24 or 48 hours), gently tap the bottom of the centrifuge tube to detach the chondrocytes from the bottom of the tube and suspend them in the liquid;
[0103] ⑧ Starting from the inoculation, replace the cells with fresh chondrogenic differentiation complete medium every 2-3 days, about 0.5 mL per tube;
[0104] ⑨ Continue induction until a cartilage ball with a diameter of 1.5 to 2 mm is formed in the tube, and then prepare for sectioning and staining.
[0105] Results Figure 3 , Figure 3 The results showed that mesenchymal stem cells expanded for 15 generations using a medium containing Forskolin and IND could effectively complete adipogenic, osteogenic and chondrogenic differentiation, and the three-way differentiation ability remained unchanged.
[0106] 3. Inhibition of cell aging in long-term cultured canine mesenchymal stem cells
[0107] 1. Canine MSC Culture in 2D System
[0108] The operation was the same as the above one, and the culture medium containing both Forskolin and INDY was used for culture. The control medium was a conventional mesenchymal stem cell culture medium, which consisted of: DMEM low glucose + 10% FBS + 5ng / mL bFGF.
[0109] 2. MSCs of P15 generation were expanded in vitro by 2D culture using culture medium containing both Forskolin and INDY, and MSCs of P10 generation were cultured in control conventional culture medium. β-gal staining and single cell size detection were performed to compare the degree of cell aging and volume differences between the two groups of cells.
[0110] Among them, Group 1 used a culture medium containing both Forskolin and INDY to perform 2D culture in vitro to expand P15 generation MSCs; Group 2 used a control culture medium to culture P10 generation MSCs.
[0111] (1) β-gal staining was performed using a β-galactosidase staining kit (cell signaling, cell senescence β-galactosidase kit, catalog number #9860S) as follows:
[0112] ① Each group of cells was plated in a 6-well plate with a seeding density of 1.0x10 6 cells / cm2, after being cultured in 2 mL of medium of each group for 48 h, the cells were stained for β-gal;
[0113] ②Preparation of kit solution:
[0114] Fixative: dilute 10X fixative with ultrapure water to 1X solution, i.e. add 300 μL 10X fixative to 2700 μL ultrapure water and prepare 3 mL staining solution;
[0115] Staining solution: Heat 10X staining solution to 37°C and stir to redissolve. Dilute 10X staining solution with ultrapure water to 1X solution, i.e., add 300 μL 10X staining solution to 2700 μL ultrapure water to prepare 3 mL staining solution.
[0116] Preparation of X-Gal stock solution: Dissolve 20 mg of X-Gal in 1 mL of DMSO to prepare a 20 mg / mL stock solution;
[0117] β-Galactosidase staining solution: Prepare 2 portions in total, each portion contains 930 μL 1X staining solution + 10 μL 100X solution A + 10 μL 100X solution B + 50 μL 20 mg / mL X-Gal storage solution, mix well and use in subsequent steps;
[0118] ③ Remove the cell culture medium, wash the plate once with 1X PBS 2mL / well, add 1mL 1X fixative to each well, and let the cells fix for 10-15 minutes at room temperature;
[0119] ④ Wash the plate twice with 1X PBS, 2 mL / well each time, and add 1 mL β-galactosidase staining solution / well;
[0120] ⑤ Incubate overnight in a regular 37°C incubator (no CO2 required);
[0121] ⑥After staining is completed and the dye is aspirated, take a photo of each well at 200X magnification.
[0122] Results Figure 4-Figure 5 The results showed that the staining ratio of MSCs in group 1 was significantly lower than that in group 2, indicating that the former was less aged than the latter.
[0123] (2) Cell size statistics
[0124] The Coutstar fluorescence cell counting instrument was used and the operation process was as follows:
[0125] ① Cell digestion: Wash each group of cells once with DMEM / F12 medium, add Accutase to digest for 5 minutes at 37℃, add 10% FBS-DMEM low-glucose medium containing fetal bovine serum to terminate the digestion, centrifuge the cells at 200g for 4 minutes, remove the supernatant, and resuspend each group of cells with DMEM low-glucose basal medium:
[0126] ② Pipette 20 μL of cell suspension, mix with 20 μL of AO / PI dye, and immediately load it into the technical plate. Use Coutstar fluorescence cell counter to detect the particle size and record the particle size.
[0127] Results Figure 6 The results showed that the diameter of MSC cells in group one was significantly lower than that in group two. The higher the degree of cell aging, the larger the single cell volume and diameter. This shows that the former is less aged than the latter.
[0128] The present invention proposes a method for promoting the in vitro expansion of canine mesenchymal stem cells and delaying cell aging by using a cAMP pathway activator Forskolin and a DYRK1 protein (dual-specificity tyrosine phosphorylation-regulated kinase) inhibitor INDY. It is verified for the first time that after MSCs are cultured for nearly 15 generations with the addition of the above-mentioned effective ingredients, there are no significant differences in surface marker proteins and tri-directional differentiation (adipogenesis, osteogenic and chondrogenic) functions compared with the early generation P5 cells. Compared with the P10 MSC cells in the control culture medium conditions, the method has obvious advantages in proliferation rate, cell aging indicators, including proliferation curve, β-galactosidase staining, single cell particle size detection and other indicators.
[0129] As a cAMP pathway activator, Forskolin has a complex effect on cells cultured in vitro. It can induce aging of mesenchymal stem cells and inhibit the proliferation of mesenchymal stem cells and tumor cells. Dual-specific tyrosine phosphorylation-regulated kinase DYRK1 is a broad-spectrum enzyme. Treatment of human pancreatic β cells cultured in vitro with DYRK1 inhibitors can effectively increase the positive ratio of cell proliferation marker Ki67, but the effect of inhibiting DYRK1 on mesenchymal stem cells has not been reported.
[0130] The present invention proposes for the first time a strategy of combining cAMP pathway activators and DYRK1 inhibitors to enhance MSC proliferation and inhibit aging. The examples of the present invention show that adding Forskolin or DYRK1 inhibitors alone to the culture medium cannot effectively enhance the in vitro proliferation ability of canine mesenchymal stem cells and inhibit cell aging caused by long-term culture for 2D culture of canine mesenchymal stem cells, but when both are added at the same time, they have a significant promoting effect on in vitro cell proliferation and significantly reduce the aging rate of mesenchymal stem cells during in vitro culture.
[0131] It should be noted that the mesenchymal stem cells used in the embodiments of the present invention are canine mesenchymal stem cells, and mesenchymal stem cells obtained from other species, such as human, cat, etc., are also included in the protection scope of the present invention.
[0132] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A culture medium for mesenchymal stem cell proliferation and inhibition of cell aging, characterized in that: Includes cAMP pathway activators and dual-specificity tyrosine phosphorylation-regulated kinase inhibitors.
2. The culture medium for mesenchymal stem cell proliferation and inhibition of cell aging according to claim 1, characterized in that: The cAMP pathway activator is forskolin.
3. The culture medium for mesenchymal stem cell proliferation and inhibition of cell aging according to claim 1, characterized in that: The dual-specific tyrosine phosphorylation-regulated kinase inhibitor is INDY.
4. The culture medium for mesenchymal stem cell proliferation and inhibition of cell aging according to claim 1, 2 or 3, characterized in that: The invention comprises a cell basal culture medium, 10% fetal bovine serum by volume, 10 μM forskolin, and 20 μM INDY.
5. The culture medium for expanding mesenchymal stem cells and inhibiting cell aging according to claim 4, characterized in that: The cell basal culture medium is DMEM low-glucose culture medium.
6. The culture medium for expanding mesenchymal stem cells and inhibiting cell aging according to claim 5, characterized in that: The configuration process includes the following steps: (1) Prepare cell basal culture medium, fetal bovine serum, 10 mM forskolin, 20 mM INDY, and pH regulator; (2) adding fetal bovine serum, forskolin, and INDY to the cell basal culture medium according to the composition and ratio of each component, and mixing evenly; (3) Adjusting pH: Detecting the pH value of the primary culture medium obtained in step (2), adjusting the pH value to 7.0-7.5, filtering, and obtaining the culture medium for mesenchymal stem cell proliferation and inhibition of cell aging. After rewarming at room temperature, the culture medium can be used for MSC culture.
7. The culture medium for expanding mesenchymal stem cells and inhibiting cell aging according to claim 6, characterized in that: The pH regulator is NaOH solution and NaHCO3 solution.
8. The culture medium for expanding mesenchymal stem cells and inhibiting cell aging according to claim 6, characterized in that: In step (1), The preparation of forskolin includes: adding forskolin into dimethyl sulfoxide and dissolving it completely to obtain a forskolin concentration of 10 mM; The preparation of INDY includes: adding INDY into dimethyl sulfoxide and dissolving it completely to obtain 20 mM concentration of INDY.
9. A method for expanding mesenchymal stem cells and inhibiting cell aging, characterized in that: The culture medium for expanding mesenchymal stem cells and inhibiting cell aging as described in any one of claims 1 to 8 is used, and a two-dimensional planar culture method is selected.
10. The method for expanding mesenchymal stem cells and inhibiting cell aging according to claim 9, characterized in that: The following steps are involved: (1) After the mesenchymal stem cells are revived or digested after passage, single cells are collected by centrifugation, resuspended in the medium for mesenchymal stem cell proliferation and inhibition of cell aging, and then concentrated to 2.0×10 6 The cells were seeded at a density of 10 cells / cm2 in a two-dimensional culture vessel and cultured statically in a cell culture incubator at 37°C and 5% CO2; (2) Subculturing after 4-5 days of culture: changing the medium every day, and observing the cell morphology and confluence. When the confluence reaches more than 80%, use trypsin or accutase to digest the cells. After terminating the digestion with a culture medium containing fetal bovine serum, centrifuge and count, and continue to repeat the inoculation method in (1) to perform two-dimensional static culture; (3) Subsequent subculturing: Refer to the procedure in (2) for culture, subculture every 4-5 days, use trypsin or accutase to digest the cultured cells into single cells, and then subculture in the same manner as above.
Citation Information
Cited By
Serum-free medium for in-vitro proliferation of adipose-derived stem cells and application of serum-free medium
CN122214257A
A serum-free culture medium for adipose-derived stem cell in vitro proliferation and application thereof
CN122214257B
